This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price delivery order is for the procurement of NEXPLANON 68 MG IMPLANTS, a specialized contraceptive device. The contract has an ultimate completion date of January 14, 2025 and is not associated with any set-aside designation.
DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This latest award reflects DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of specialized prescription drugs and pharmacy services to support the medical needs of Department of Defense healthcare facilities nationwide.
Generated 3/23/25, 12:45 AM